chr1-152302945-T-C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_002016.2(FLG):āc.11941A>Gā(p.Ser3981Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000206 in 1,614,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002016.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FLG | NM_002016.2 | c.11941A>G | p.Ser3981Gly | missense_variant | 3/3 | ENST00000368799.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FLG | ENST00000368799.2 | c.11941A>G | p.Ser3981Gly | missense_variant | 3/3 | 1 | NM_002016.2 | P1 | |
FLG-AS1 | ENST00000653548.1 | n.390-29638T>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152198Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000199 AC: 50AN: 251390Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135856
GnomAD4 exome AF: 0.000205 AC: 300AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.000208 AC XY: 151AN XY: 727242
GnomAD4 genome AF: 0.000217 AC: 33AN: 152316Hom.: 0 Cov.: 31 AF XY: 0.000134 AC XY: 10AN XY: 74470
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 01, 2022 | The c.11941A>G (p.S3981G) alteration is located in exon 3 (coding exon 2) of the FLG gene. This alteration results from a A to G substitution at nucleotide position 11941, causing the serine (S) at amino acid position 3981 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | FLG: BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at